Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers. Haykal MM, Rodrigues-Ferreira S, El Botty R, Sourd L, et al. Cancer Lett 2025;620:217665.

Read + Share

Amedeo Smart

Independent Medical Education

Haykal MM, Rodrigues-Ferreira S, El Botty R, Sourd L, et al. Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers. Cancer Lett 2025;620:217665.
PMID: 40127815